Competing risk analysis of cardiovascular death in patients with primary gallbladder cancer
- PMID: 35920057
- PMCID: PMC9939154
- DOI: 10.1002/cam4.5104
Competing risk analysis of cardiovascular death in patients with primary gallbladder cancer
Abstract
Background: Developments in medical technology are resulting in continuous decreases in the cancer mortality rate of patients with gallbladder cancer, while non-cancer deaths in cancer patients are becoming more common. The main cause of this is cardiovascular mortality (CVM). The purpose of this study was to determine the CVM risk in patients with primary gallbladder cancer (PGC).
Methods: We extracted information on patients in the SEER database who were diagnosed with PGC from 2004 to 2015, compared CVM in patients with PGC with the general United States population, and calculated standardized mortality rates (SMRs) and the absolute excess risk. A competing risks model was used to identify and analyze the independent risk factors for cardiovascular death in patients with PGC.
Results: This study included 5925 patients, 247 of whom died from cardiovascular disease. The SMR of cardiovascular death in patients with PGC was 15.84 (95% confidence interval: 15.83-15.85), and the SMR was slightly lower in male than female patients. The competing risks analysis indicated that age, marital status, cancer cell differentiation, chemotherapy status, and year of diagnosis were risk factors for cardiovascular death in patients with PGC.
Conclusions: The CVM risk is considerably higher in patients with PGC than in the general population. It is therefore very necessary to apply cardioprotective interventions to patients with PGC.
Keywords: cancer education; cancer risk factors; cholangiocarcinoma; clinical cancer research; epidemiology.
© 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Cardiovascular mortality risk among small bowel adenocarcinoma patients: a population-based study.BMC Public Health. 2025 Jan 8;25(1):97. doi: 10.1186/s12889-025-21279-5. BMC Public Health. 2025. PMID: 39780085 Free PMC article.
-
High cardiovascular mortality risk among older merkel cell carcinoma patients.BMC Geriatr. 2024 Aug 9;24(1):670. doi: 10.1186/s12877-024-05222-8. BMC Geriatr. 2024. PMID: 39123101 Free PMC article.
-
Cardiovascular-Specific Mortality among Gastrointestinal Stromal Tumor Patients: A Population-Based Analysis.Oxid Med Cell Longev. 2023 Feb 14;2023:3619306. doi: 10.1155/2023/3619306. eCollection 2023. Oxid Med Cell Longev. 2023. PMID: 36825080 Free PMC article.
-
Competing risk analysis of cardiovascular death in breast cancer: evidence from the SEER database.Transl Cancer Res. 2023 Dec 31;12(12):3591-3603. doi: 10.21037/tcr-23-1163. Epub 2023 Dec 8. Transl Cancer Res. 2023. PMID: 38192997 Free PMC article.
-
Long-term risks of cardiovascular-specific mortality among myeloproliferative neoplasms patients.Ther Adv Hematol. 2024 Oct 28;15:20406207241290886. doi: 10.1177/20406207241290886. eCollection 2024. Ther Adv Hematol. 2024. PMID: 39478808 Free PMC article.
Cited by
-
Analysis of competing risks of cardiovascular death in patients with hepatocellular carcinoma: A population-based study.Medicine (Baltimore). 2023 Dec 22;102(51):e36705. doi: 10.1097/MD.0000000000036705. Medicine (Baltimore). 2023. PMID: 38134062 Free PMC article.
-
Onco-immunity and therapeutic application of amygdalin: A review.J Oral Biol Craniofac Res. 2023 Mar-Apr;13(2):155-163. doi: 10.1016/j.jobcr.2022.12.010. Epub 2022 Dec 28. J Oral Biol Craniofac Res. 2023. PMID: 36618007 Free PMC article. Review.
-
Non cancer causes of death after gallbladder cancer diagnosis: a population-based analysis.Sci Rep. 2023 Aug 23;13(1):13746. doi: 10.1038/s41598-023-40134-4. Sci Rep. 2023. PMID: 37612302 Free PMC article.
-
Cardiovascular mortality risk among small bowel adenocarcinoma patients: a population-based study.BMC Public Health. 2025 Jan 8;25(1):97. doi: 10.1186/s12889-025-21279-5. BMC Public Health. 2025. PMID: 39780085 Free PMC article.
-
Interplay of Cardiometabolic Syndrome and Biliary Tract Cancer: A Comprehensive Analysis with Gender-Specific Insights.Cancers (Basel). 2024 Oct 9;16(19):3432. doi: 10.3390/cancers16193432. Cancers (Basel). 2024. PMID: 39410050 Free PMC article. Review.
References
-
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209‐249. - PubMed
-
- Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118:1591‐1602. - PubMed
-
- Akhtar‐Danesh N, Akhtar‐Danseh GG, Seow H, Shakeel S, Finley C. Treatment modality and trends in survival for gallbladder cancer: a population‐based study. J Gastrointest Cancer. 2021;52:256‐262. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical